reference/27006328

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27006328

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial
endingPage	e430
issn	2352-3018
issueIdentifier	9
pageRange	e421-e430
publicationName	The lancet. HIV
startingPage	e421
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_05f909eac31330e4ad45393064a98451 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dec46f7acb56735290bbc809033a0e3d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1585c33aa4f47deb808f7f0ec951591b
bibliographicCitation	BREATHER (PENTA 16) Trial Group. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial. Lancet HIV. 2016 Sep;3(9):e421–30. PMID: 27562743; PMCID: PMC4995440.
date	201609
identifier	https://doi.org/10.1016/s2352-3018%2816%2930054-6 https://pubmed.ncbi.nlm.nih.gov/PMC4995440 https://pubmed.ncbi.nlm.nih.gov/27562743
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43213 https://portal.issn.org/resource/ISSN/2352-3018
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial
discusses	http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0258297 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0028839
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D048588Q000008 http://id.nlm.nih.gov/mesh/D018894Q000008 http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D015658Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005602 http://id.nlm.nih.gov/mesh/D048588Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D000480 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018894Q000627 http://id.nlm.nih.gov/mesh/D018894Q000009 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D015497Q000187 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D015658Q000821 http://id.nlm.nih.gov/mesh/D018791 http://id.nlm.nih.gov/mesh/D019380Q000009 http://id.nlm.nih.gov/mesh/D019380Q000627 http://id.nlm.nih.gov/mesh/D048588Q000009 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6491 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8333 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5918 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7886 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_768a9366cdd5c2c67bb21a934b60bee3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79ebb16594f0b183a59ea5e59d0732b9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9350 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907

Showing number of triples: 1 to 69 of 69.